ArticleCancers2022

Increased Activity of a NK-Specific CAR-NK Framework Targeting CD3 and CD5 for T-Cell Leukemias.

Elisaveta Voynova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.